Market Cap 3.75B
Revenue (ttm) 1.36B
Net Income (ttm) 167.68M
EPS (ttm) N/A
PE Ratio 16.74
Forward PE 16.30
Profit Margin 12.32%
Debt to Equity Ratio 1.08
Volume 263,800
Avg Vol 897,132
Day's Range N/A - N/A
Shares Out 46.81M
Stochastic %K 43%
Beta 0.30
Analysts Strong Sell
Price Target $91.70

Company Profile

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLy...

Industry: Medical Devices
Sector: Healthcare
Phone: 781 848 7100
Address:
125 Summer Street, Boston, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 3:33 PM
Actionable Trade Alert for $HAE: Market Context: $HAE is currently trading at $80.01, showing a bearish sentiment with an RSI of 36.71, indicating potential oversold conditions. The price is above the 30-day moving average (MA30) of $79.89 but well above the 50-day moving average (MA50) of $69.62, suggesting a possible upward correction. Directional Bias: Given the RSI below 40 and proximity to the 60-day low of $47.72, we anticipate a rebound towards the 60-day high of $87.32. Trade Plan: - Suggested Entry: $80.01 - Stop Loss: $76.67 (below recent support, approximately 4.2% risk) - Take Profit Targets: 1. $84.00 (5% gain) 2. $87.00 (8.7% gain) 3. $93.00 (16.25% gain, achieving over 17% ROI) Monitor the trade closely for any signs of reversal or increased volatility. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:29 PM
Actionable Trade Alert for $HAE: Market Context: $HAE closed at $79.9, currently sitting near the midpoint of its 60-day range ($47.32 - $87.32). The RSI of 47.59 indicates a neutral momentum, suggesting potential for upward movement. Directional Bias: The stock is above the 30-day MA (77.35) and significantly above the 50-day MA (66.53), indicating bullish sentiment in the short term. The lack of a 200-day MA limits long-term trend analysis but supports a cautious bullish outlook given the current price action. Trade Plan: - Suggested Entry: $80.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $77.00 (below the 30-day MA for protection) - Take Profit Targets: 1. $83.50 (4% gain) 2. $86.00 (6.5% gain) 3. $93.50 (17% gain) This plan capitalizes on potential upward movement while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Outperform with a target price of 75 → 90.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:14 AM
Actionable Trade Alert for $HAE: Market Context: $HAE closed at $81.11, showing a stable position above its 30-day moving average (MA30) of $75.38 and 50-day moving average (MA50) of $65.31. The RSI at 54.18 indicates a neutral to slightly bullish momentum, suggesting potential for upward movement. Directional Bias: The price is currently closer to the 60-day high of $87.32 than the low of $47.32, indicating bullish sentiment. The ATR of 2.42 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $81.50 - Stop Loss: $78.50 (3% below entry) - Take Profit Targets: 1. $84.00 (Target 1 - 3% ROI) 2. $87.00 (Target 2 - 6.1% ROI) 3. $95.00 (Target 3 - 16.8% ROI) This plan offers a potential ROI of over 17% on the third target while maintaining a manageable risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:10 PM
Baird updates rating for Haemonetics ( $HAE ) to Outperform, target set at 87 → 99.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 11:37 AM
Needham updates rating for Haemonetics ( $HAE ) to Hold.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:47 AM
Actionable Trade Alert for $HAE: Market Context: $HAE closed at $83.49, showing strong momentum with an RSI of 66.07, indicating it's nearing overbought territory but still has room for movement. The stock is above its 30-day MA of 74.44 and 50-day MA of 64.76, suggesting a bullish trend. Directional Bias: The recent price action is positive, supported by the proximity to the 60-day high of 87.32. The ATR of 2.33 indicates moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.00% risk) - Take Profit Targets: 1. $86.00 (3.00% gain) 2. $89.00 (6.00% gain) 3. $97.00 (16.25% gain) With these targets, the third take profit offers a potential ROI of over 17%. Monitor the price action closely and adjust stop loss as needed to protect gains. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 7:48 PM
JP Morgan has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Neutral with a target price of 62 → 74.
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 12:12 PM
HAE might be setting up for a quiet comeback — here’s what stands out. $HAE is seeing a Hospital rebound and rising NexSys PCS adoption, which boosts growth prospects even as FX and solvency pressures linger. That mix makes the hold-or-sell debate a lot more interesting right now. Full breakdown here 👉 https://www.zacks.com/stock/news/2803441/is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2803441-teaser-24535&ADID=SYND_STOCKTWITS_TWEET_2_2803441_TEASER_24535
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 11:12 AM
$HAE’s Hospital business is back on the growth track! 🚀 With a 5% revenue boost in the Hospital business and 12% sales growth in Blood Management Technologies, Haemonetics is positioned to capitalize on dynamic market conditions. However, watch out for foreign exchange impacts and solvency concerns. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2803441/is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2803441-body-24534&ADID=SYND_STOCKTWITS_TWEET_2_2803441_BODY_24534
0 · Reply
Latest News on HAE
Top 2 Health Care Stocks You May Want To Dump This Month

Dec 2, 2025, 9:01 AM EST - 25 days ago

Top 2 Health Care Stocks You May Want To Dump This Month

EXAS


Haemonetics Is Still Undervalued, Even After The Rally

Nov 7, 2025, 10:41 AM EST - 7 weeks ago

Haemonetics Is Still Undervalued, Even After The Rally


Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

Aug 9, 2025, 10:53 PM EDT - 4 months ago

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript


Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

May 10, 2025, 1:05 PM EDT - 8 months ago

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript


Haemonetics Announces Executive Leadership Updates

Mar 3, 2025, 4:10 PM EST - 10 months ago

Haemonetics Announces Executive Leadership Updates


Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 12:19 PM EST - 11 months ago

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript


Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript

May 10, 2024, 12:25 AM EDT - 1 year ago

Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript


Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript

Feb 8, 2024, 12:24 PM EST - 2 years ago

Haemonetics Corporation (HAE) Q3 2024 Earnings Call Transcript


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 3:33 PM
Actionable Trade Alert for $HAE: Market Context: $HAE is currently trading at $80.01, showing a bearish sentiment with an RSI of 36.71, indicating potential oversold conditions. The price is above the 30-day moving average (MA30) of $79.89 but well above the 50-day moving average (MA50) of $69.62, suggesting a possible upward correction. Directional Bias: Given the RSI below 40 and proximity to the 60-day low of $47.72, we anticipate a rebound towards the 60-day high of $87.32. Trade Plan: - Suggested Entry: $80.01 - Stop Loss: $76.67 (below recent support, approximately 4.2% risk) - Take Profit Targets: 1. $84.00 (5% gain) 2. $87.00 (8.7% gain) 3. $93.00 (16.25% gain, achieving over 17% ROI) Monitor the trade closely for any signs of reversal or increased volatility. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:29 PM
Actionable Trade Alert for $HAE: Market Context: $HAE closed at $79.9, currently sitting near the midpoint of its 60-day range ($47.32 - $87.32). The RSI of 47.59 indicates a neutral momentum, suggesting potential for upward movement. Directional Bias: The stock is above the 30-day MA (77.35) and significantly above the 50-day MA (66.53), indicating bullish sentiment in the short term. The lack of a 200-day MA limits long-term trend analysis but supports a cautious bullish outlook given the current price action. Trade Plan: - Suggested Entry: $80.50 (slightly above the last close to confirm upward momentum) - Stop Loss: $77.00 (below the 30-day MA for protection) - Take Profit Targets: 1. $83.50 (4% gain) 2. $86.00 (6.5% gain) 3. $93.50 (17% gain) This plan capitalizes on potential upward movement while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Outperform with a target price of 75 → 90.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:14 AM
Actionable Trade Alert for $HAE: Market Context: $HAE closed at $81.11, showing a stable position above its 30-day moving average (MA30) of $75.38 and 50-day moving average (MA50) of $65.31. The RSI at 54.18 indicates a neutral to slightly bullish momentum, suggesting potential for upward movement. Directional Bias: The price is currently closer to the 60-day high of $87.32 than the low of $47.32, indicating bullish sentiment. The ATR of 2.42 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $81.50 - Stop Loss: $78.50 (3% below entry) - Take Profit Targets: 1. $84.00 (Target 1 - 3% ROI) 2. $87.00 (Target 2 - 6.1% ROI) 3. $95.00 (Target 3 - 16.8% ROI) This plan offers a potential ROI of over 17% on the third target while maintaining a manageable risk. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:10 PM
Baird updates rating for Haemonetics ( $HAE ) to Outperform, target set at 87 → 99.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 11:37 AM
Needham updates rating for Haemonetics ( $HAE ) to Hold.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:47 AM
Actionable Trade Alert for $HAE: Market Context: $HAE closed at $83.49, showing strong momentum with an RSI of 66.07, indicating it's nearing overbought territory but still has room for movement. The stock is above its 30-day MA of 74.44 and 50-day MA of 64.76, suggesting a bullish trend. Directional Bias: The recent price action is positive, supported by the proximity to the 60-day high of 87.32. The ATR of 2.33 indicates moderate volatility, allowing for potential price swings. Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.00% risk) - Take Profit Targets: 1. $86.00 (3.00% gain) 2. $89.00 (6.00% gain) 3. $97.00 (16.25% gain) With these targets, the third take profit offers a potential ROI of over 17%. Monitor the price action closely and adjust stop loss as needed to protect gains. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 7:48 PM
JP Morgan has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Neutral with a target price of 62 → 74.
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 12:12 PM
HAE might be setting up for a quiet comeback — here’s what stands out. $HAE is seeing a Hospital rebound and rising NexSys PCS adoption, which boosts growth prospects even as FX and solvency pressures linger. That mix makes the hold-or-sell debate a lot more interesting right now. Full breakdown here 👉 https://www.zacks.com/stock/news/2803441/is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2803441-teaser-24535&ADID=SYND_STOCKTWITS_TWEET_2_2803441_TEASER_24535
0 · Reply
ZacksResearch
ZacksResearch Dec. 12 at 11:12 AM
$HAE’s Hospital business is back on the growth track! 🚀 With a 5% revenue boost in the Hospital business and 12% sales growth in Blood Management Technologies, Haemonetics is positioned to capitalize on dynamic market conditions. However, watch out for foreign exchange impacts and solvency concerns. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2803441/is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2803441-body-24534&ADID=SYND_STOCKTWITS_TWEET_2_2803441_BODY_24534
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:41 AM
$HAE Actionable Trade Alert: Current market context indicates a strong bullish sentiment as the last close is $84.31, with an RSI of 76.28, suggesting overbought conditions. However, the upward momentum is supported by a rising 30-day moving average (MA30) at $73.32 and a 50-day moving average (MA50) at $64.07. The stock is nearing its 60-day high of $87.32, indicating potential resistance. Directional bias remains bullish due to the strong price action. Suggested entry point is at $84.31. Set a stop loss at $81.85 (below recent support). Take Profit Targets: 1. TP1: $87.00 (3.19% gain) 2. TP2: $90.00 (6.38% gain) 3. TP3: $98.75 (17.14% gain) This plan allows for a strategic exit as the price approaches resistance levels while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 1:55 PM
Citigroup updates rating for Haemonetics ( $HAE ) to Neutral, target set at 77 → 88.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 7:57 PM
$HAE Current Stock Price: $86.67 Contracts to trade: $85 HAE Dec 19 2025 Call Entry: $0.15 Exit: $0.21 ROI: 42% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:44 AM
$HAE Actionable Trade Alert: Market Context: $HAE is currently experiencing strong momentum, closing at $83.84. The RSI at 88.82 indicates overbought conditions, suggesting a potential pullback. However, the price is above the 30-day MA of 70.93 and the 50-day MA of 62.59, indicating bullish sentiment. Directional Bias: The recent high of $85.48 and low of $47.32 over the past 60 days highlight a significant upward trend. The strong position above key moving averages supports a bullish outlook, but caution is warranted due to the high RSI. Trade Plan: - Suggested Entry: $83.84 - Stop Loss: $80.00 (3.4% below entry) - Take Profit Targets: 1. $87.00 (3% gain) 2. $90.00 (7.5% gain) 3. $98.00 (17% gain) This plan allows for a solid risk-reward ratio, with a potential 17% ROI on the third target. Monitor the RSI and price action closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:33 AM
$HAE Trade Alert: Current market conditions show a strong bullish sentiment with an RSI of 86.94, indicating overbought conditions. The last close at $83.03 is near the 60D high of $85.23, suggesting resistance in this area. The MA30 (69.84) and MA50 (61.87) are significantly below the current price, indicating a strong upward trend. Action Plan: - Suggested Entry: $83.50 (to capitalize on potential breakout above $85.23) - Stop Loss: $80.90 (to limit downside risk) - Take Profit Targets: 1. $86.50 (approx. 3% gain) 2. $90.00 (approx. 8% gain) 3. $97.00 (approx. 17% gain) With the current momentum and high RSI, a breakout above $85.23 could lead to further gains. Monitor price action closely around the entry point to adjust strategy if necessary. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:32 AM
$HAE Analysis: The last close at $83.81 indicates a strong upward momentum, especially with an RSI of 91.25, suggesting overbought conditions. The 30-day moving average (MA30) at 67.7 and 50-day moving average (MA50) at 60.45 further confirm the bullish trend, as the price is significantly above these averages. The recent 60-day high of $84.19 indicates resistance, while the low of $47.32 shows the potential for significant gains. Actionable Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.0% risk) - Take Profit Targets: 1. $86.00 (2.7% gain) 2. $89.00 (6.8% gain) 3. $98.00 (17% gain) With the current market context and directional bias favoring upward movement, this trade plan allows for a structured approach to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:07 PM
$HAE Analysis: The last close at $83.81 indicates a strong upward momentum, especially with an RSI of 91.25, suggesting overbought conditions. The 30-day moving average (MA30) at 67.7 and 50-day moving average (MA50) at 60.45 further confirm the bullish trend, as the price is significantly above these averages. The recent 60-day high of $84.19 indicates resistance, while the low of $47.32 shows the potential for significant gains. Actionable Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.0% risk) - Take Profit Targets: 1. $86.00 (2.7% gain) 2. $89.00 (6.8% gain) 3. $98.00 (17% gain) With the current market context and directional bias favoring upward movement, this trade plan allows for a structured approach to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
stockanalysis_
stockanalysis_ Dec. 5 at 1:07 AM
Overbought Stocks: $MAGH $SND $HAE $EXAS $CDTX View the entire list here: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
Estimize
Estimize Dec. 1 at 2:03 PM
Wall St is expecting 1.25 EPS for $HAE Q3 [Reporting 02/10 BMO] http://www.estimize.com/intro/hae?chart=historical&metric_name=eps&utm_cont
0 · Reply
Cutlass
Cutlass Nov. 28 at 3:12 PM
$HAE Out for now - solid run from 48 💥
1 · Reply
Cutlass
Cutlass Nov. 25 at 3:37 PM
$HAE Trim a bit 81.25 and every dollar up 👀
0 · Reply
Cutlass
Cutlass Nov. 24 at 5:43 PM
$HAE Trim a tad at 80 🍎
0 · Reply